 SOUTH SAN FRANCISCO, Calif., Feb. 16, 2022 GLOBE NEWSWIRE -- Calithera Biosciences, Inc. Nasdaq: CALA, a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the companys founder, president and chief executive officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 4:20 p.m. Eastern Time. An archived replay of the webcast will be available on the Companys website for 30 days following the live presentation. 